Herpes simplex virus encephalitis (HSE) is the most common cause of endemic, fatal encephalitis in industrial countries (15) . Treatment with acyclovir, when initiated soon after the onset of symptoms, ran decrease the high mortality rate associated with this disease. Until recently, however, the early diagnosis of HSE has been restricted to the detection of herpes simplex virus (HSV) in brain biopsy material. Recently, the polymerase chain reaction (PCR), allowing the detection of HSV DNA in cerebrospinal fluid (CSF) samples, has been shown to be a promising diagnostic tool (1, 5, (10) (11) (12) (13) (14) .
In the present study, the value of a previously established HSV PCR assay (12) applied to HSE diagnosis under routine conditions was investigated. Some 257 patients with clinically suspected HSE, from whom at least one CSF sample was obtained within the first 10 days of disease, were investigated by HSV PCR. As described previously (12) , PCR was done in a 100-,ul reaction mixture containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2, 200 ,uM each deoxynucleoside triphosphate (dATP, dCTP, dGTP, and dUTP), 100 pM each of the primers HS 13 (ACGAC GACGTCCGACGGCGA) and HS 14 (GTGCTGGTGCTG GACGACAC) (7, 12) , 10 ,ul of CSF, and 2 U of Taq polymerase (Perkin-Elmer-Cetus). The mixture was overlaid with paraffin oil, and 35 PCR cycles were performed (94°C-40°C-68°C, each for 1 min). Strict precautions were taken to exclude contamination during the PCR procedure (6, 12) . For the specific detection of the amplified fragments, slot blot hybridization was carried out as described previously (12) . The hybridization results were analyzed semiquantitatively, using primary human foreskin fibroblasts infected with HSV type 1 strain 539 in different concentrations as positive standards. The result obtained from the dilution corresponding to 10 infectious units was used as a cutoff value (12) . After hybridization, the radioactive signals of the probe bound to the individual samples were determined. The sample counts per minute were compared with the test cutoff counts per minute and are indicated as x-fold cutoff counts per minute. All CSF and serum samples available were screened for the presence of HSV-specific antibodies by complement fixation test (4), using 2 U of antigen, and by * Corresponding author.
immunoglobulin M-and G-specific solid-phase enzymelinked immunosorbent assays, using HSV-type 1 strain 539-infected HeLa cells as antigen (3) . Samples were tested in serial twofold dilutions (1:100 to 1:51,200). HSE was considered serologically proven when at least a fourfold increase in the CSF/serum HSV antibody ratio was observed, not accompanied by a similar increase in unrelated antigens (9) .
As shown in Table 1 , the PCR proved to be superior to serology, detecting 14 additional HSE cases. It also allowed a much earlier diagnosis than antibody testing in all cases. In two patients, however, only one of two CSF samples was positive by PCR. The diagnosis of HSE was in agreement with clinical and radiodiagnostic findings in all PCR-positive patients. In 105 PCR-negative cases, another cause for the clinical symptoms was proven. No information about follow-up was obtained from most of the remaining PCRnegative patients.
We then assessed whether, in the absence of HSE, latent or reactivated HSV infection may cause positive PCR results. Control CSF samples from 145 latently HSV-infected patients (presence of HSV-specific immunoglobulin G antibodies), with diseases of the central nervous system other than HSE, were all negative by PCR. In addition, CSF samples from three patients who were just undergoing HSV reactivation, proven by serology or virus isolation, without clinical evidence of HSE also yielded negative PCR results. Thus, positive PCR results obtained with CSF samples are highly specific for HSE.
As false-negative results were obtained with two CSF samples (Table 1) , we analyzed which factors could possibly influence the amount of HSV DNA present in CSF during HSE. The PCR signal intensity obtained with 10 individual CSF samples from the PCR-positive patients shown in Table  1 could be compared with the CSF cell number available from these samples. The statistical evaluation (Kendall T correlation) indicated no significant correlation between signal intensity and CSF cell number ( = 0.09; P > 0.1). The PCR signal intensity did show, however, a slight association with the patient's age (Table 2) (T = 0.24; P < 0.1) and a significant correlation to the clinical severity of disease (Table 3 ) (T = 0.46; P < 0.01).
Another factor possibly influencing PCR signal intensity is the time of CSF sampling in the course of disease. We have investigated whether there is a relationship between PCR signal intensities and the length of the interval between onset of disease and onset of acyclovir treatment or the duration of therapy. The PCR results from 13 patients from whom exact data concerning onset of disease and therapy were available were statistically analyzed. Two different CSF samples were included from four patients. A second-order polynomial regression was performed (Fig. 1) , and this indicated a statistically significant (P < 0.05) relationship between initiation of acyclovir therapy and increase of PCR signals, independent of when in the course of disease the treatment was started. The highest signals were reached at day 5 to 6 of therapy. These unexpected results may be explained by the generation of a high amount of small HSV DNA fragments when HSV replicates in the presence of acyclovir (8) . This would also be consistent with previous findings showing that HSV DNA is present as free DNA in the CSF during HSE (13) We conclude that the semiquantitative PCR assay is a reliable, specific, and sensitive tool for the early diagnosis of HSE. According to our data, however, a negative PCR result cannot completely exclude HSE and does not itself provide justification for the termination of acyclovir treatment.
